Category Archives: Transhuman News

Longevity Investors Conference brought together high level scientists, clinicians and investors who all agreed on one big goal: Bringing the concept of longevity to life. Longevity experts and visionaries joined the conference, such as George Church, professor of genetics at Harvard Medical School; Aubrey de Grey, chief of science offices at SENS Research Foundation; Brian Kennedy, director at Center for Healthy Longevity and professor of the biochemistry and physiology departments at National University of Singapore; Charles Brenner from Alfred E. Mann Family Foundation and chair of diabetes and cancer metabolism at Beckman Research Institute of City of Hope; Christian Angermayer, founder of Apeiron Investment Group; Eric Verdin, president and CEO of Buck Institute for Research on Ageing; Nir Barzilai, director of the Institute for Ageing Research at the Albert Einstein College of Medicine; Michael Greve, founder of Forever Healthy Foundation; Evelyne Yehudit Bischof, associate professor, internal medicine specialist and longevity physician at Human Longevity Inc.; Alex Zhavoronkov, founder and CEO of Insilico Medicine; Phil Newman, founder of First Longevity and editor-in-chief at Longevity.Technology; Wei-Wu He, executive chairman at Human Longevity Inc., chairman and CEO of CASI Pharmaceuticals Inc. and chairman and founder of Genetron Health; and many more.

Longevity Investors Conference, being the most exclusive conference for longevity investors, brought together over 130 investors from around the globe. The investors as well as the speakers had the chance to see the Startup Showcase that took place on Day One of the conference in partnership with Phil Newman from Longevity Technology. The Startup Showcase provided the chance to some of the most promising longevity startups to present their work and ideas, such as Tom Weldon, founder, chairman and CEO of Ponce De Leon Health; Nikolina Lauc, co-founder and CEO of GlycanAge; Stan Watowich, founder and interim CEO of Ridgeline Therapeutics; Owen Phillips, CEO of BrainKey; Nika Pintar, co-founder and CEO of Ani Biome; and Bruno Balen co-founder of Ani Biome.

The venue, Le Grand Bellevue Hotel in Gstaad, recently rated the Hotel of the Year by Swiss media, was privatized for the LIC guests ensuring an exclusive networking experience. There were many networking opportunities over the course of the two days during the networking dinners and lunches and especially during coffee breaks and receptions held in the Longevity Lounge, where guests could get the exclusive chance to experience the latest trends in longevity therapies and treatments from exhibitors.

The ending of the Longevity Investors Conference was marked by a gala dinner, during which the Maximon Longevity Prize Award Ceremony took place. Elisabeth Roider, partner and chief scientific and medical officer at Maximon explained from a scientific point of view that translation efforts from computational biology to wet lab approaches to clinical trials are needed on the way. Many small steps will be required while the big picture should be in place. The prize is especially important, as it highlights the effort that is needed to identify safe and new ways to target ageing, the need for large clinical trials, which investigate the effect of interventions on ageing, and the importance of mental health, platforms and AI in future longevity medicine.

Marc Bernegger, one of the driving forces behind the conference, said: There are more and more traditional investors joining the longevity space, which creates massive investment opportunities. The special setup of this years conference enables not only knowledge exchange but also effective community-building, which is very unique for the industry and has never happened before to this extent. Berneggers partner and LIC co-founder, Dr. Tobias Reichmuth, added: The longevity industry will be one of the biggest investment opportunities over the next decade, expected to be worth at least $600 billion by 2025. It is experiencing a great momentum, and this is the ideal time to use it in favor of educating and spreading the information to investors. In an ocean of scientific-oriented conferences, a professional and global investor-focused longevity conference such as LIC provides an opportunity for the industrys top investors and innovators to get acquainted with recent developments and breakthroughs.

The next Longevity Investors Conference will be held in the Autumn of 2023. Participation is open for registration on the website.

Contact

View original post here:
The Longevity Investors Conference Gstaad brought together longevity experts and deep-pocketed investors - Cointelegraph

halioua began 2020 with $5.1 million in funding. By way of thanks she sent all of her investors, including Rosen, fluffy toy puppies wearing company bandanas. She secured an office on the edge of downtown San Francisco, but the lease began in March, the same month the Bay Area became the first part of the US to enter pandemic lockdown. Her companys formative months, and first hires, took place via Zoom, Slack, and eventually socially distanced meetups. Halioua raised another $6 million and hired scientists, veterinarians, and an expert in getting new animal drugs past the FDA.

She embraced the role of dog company CEOpainting a mural of a giant German shepherd in Loyals office and ordering shirts with the slogan Save the dogs, save the world. She adopted a fluffy white husky named Wolfie, whom she has described as her cofounder and Loyals chief evangelist. Her management style, she says, was informed by her bad experiences at Oxford. When she talks to her team about her goals or beliefs, she tries to pair her statements with evidence to convince her workers that the boss is being straight with them. Even if you dont trust me, you still know this is true, she says.

Haliouas new science team, including a scientist who previously led aging research at pharma giant Regeneron, helped refine her original idea. They identified a compound they believed could be given to young dogs of the largest breeds, such as French mastiffs, to delay their accelerated aging process. They found a second compound they thought could target processes that cause cognitive decline and kidney problems in older dogs of all sizes.

As her company gained traction, Halioua noticed certain patterns in her business interactions. She tried to recruit women investors but found it difficult because there werent many to ask. When she met with investors who were men, some would try to flip a business meeting into a date, and others would confidently explain science to her that she knew inside out. Mostly she brushed off such momentsher time at Oxford had lowered her expectations of those with more power and prestige than her.

She often felt different. Describing herself as an Oxford dropout helped convince people to take her seriouslynever mind that she had left her PhD in part due to dissatisfaction with a harassment investigation, a circumstance missing from the dropout tales of archetypal boy geniuses like Mark Zuckerberg. She listened to hundreds of Silicon Valley podcasts to try to learn the industrys patois. She trained herself to smile less and wrote in a blog post aimed at women entrepreneurs: I come off as more of a grump now, but I am a grump who has the money she needs to build her company.

In the spring of 2021, Halioua published a blog post about her Oxford PhD supervisor titled The Gifts of My Harasser, leaving him nameless. She described the paradox of one of her worst experiences laying a foundation stone for her later successes by teaching her to be skeptical of social hierarchies and institutional power. Its been two years since I left. I am not broken anymore, but I still feel the cracks, she wrote. His abuse shattered my preconceived notions of how the world worked and cleared a path I otherwise never would have found.

See original here:
The Search for a Pill That Can Help Dogsand HumansLive Longer - WIRED

In ESC Heart Failure, researchers have commented about the correlation between a poor gut microbiome and aging of the heart [1].

Research increasingly suggests that the quality and composition of the gut microbiome may play a role as important as exercise on health. The gut microbiome is a living ecosystem that is made up of many types of bacteria, fungi, and other microbes. It plays an important role in health by aiding digestion, regulating the immune system, and supporting many other beneficial processes.

The relationship between the gut microbiome and immune system is a two-way street, with each supporting the other. The immune system ensures that helpful beneficial bacteria thrive while keeping populations of harmful bacteria down.

Unfortunately, as with many things during aging, the immune system goes into decline in a process called immunosenescence. This makes the immune system less able to respond to invading pathogens and maintain the health and diversity of the microbiome.

This is likely one of the reasons why microbiome health also tends to decline with age. Populations of beneficial bacteria dwindle, while harmful, pro-inflammatory bacteria begin to grow in numbers.

The commentary we want to highlight today sees researchers discussing the correlations between the presence and numbers of specific types of gut bacteria and the aging of the heart.

Changes in cardiac structure and function occur with ageing and may lead towards ageing-related cardiovascular disease. Recent explorations into intestinal microbiota have provided important insights into shifts in microbial composition that occur in response to cardiovascular disease pathogenesis. Several proposed mechanisms include altered gut permeability, endotoxemia, and the systemic effect of metabolites including trimethylamine (TMA), short-chain fatty acids (SCFA), and secondary bile acids. However, causal associations between gut microbes and left ventricular (LV) function have yet to be proven. We sought to determine whether gut microbial composition is associated with left ventricular myocardial relaxation, an early manifestation of myocardial ageing, among older adults.

While the size of this study is small, the data is still interesting and suggests that there is at least some correlation between gut microbiome health and heart aging.

The ideal situation would be to run a larger study of this kind to confirm the correlation and potentially look at interventions to address it. A crude but demonstrated way to improve the microbiome is the use of fecal transplantation, in which the microbiome from younger healthy individuals is transferred to older ones. Seeding the aged gut with beneficial bacteria via probiotics may be another approach worth exploring.

One thing is certain: the role of the gut microbiome in aging is becoming increasingly appreciated. Some researchers even suggest that it could be an additional reason why we age, though the jury is still out as to whether it is a cause or a consequence of one of the established aging processes.

[1] Wong, J. J., Purbojati, R. W., Tan, R. S., Pettersson, S., & Koh, A. S. (2022). Distinct gut microbiota composition among older adults with myocardial ageing. ESC heart failure, 10.1002/ehf2.14139. Advance online publication. https://doi.org/10.1002/ehf2.14139

Read more:
Aging of the Heart Correlates With a Poor Gut Microbiome - Lifespan.io News

Results from the study evaluating AditxtScore for neutralizing antibodies ("NAb") were published in the Journal of Theoretical Biology

RICHMOND, Va., October 12, 2022--(BUSINESS WIRE)--Aditxt, Inc. (Nasdaq: ADTX) ("Aditxt" or the "Company"), a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announces publication of a mathematical model for predicting the durability and rate of decay of neutralizing antibodies to SARS-CoV-2 in a peer-reviewed research paper in the Journal of Theoretical Biology.

Titled, "A mathematical model of the within-host kinetics of SARS-CoV-2 neutralizing antibodies following COVID-19 vaccination," the publication describes a model developed with Dr. Lisette de Pillis, a professor of life sciences and mathematics at Harvey Mudd College.

NAb inhibit viral binding to the human cell receptor thereby reducing its ability to infect the cell. Evaluating NAb levels and their durability over time is important in understanding unique immune responses and the likelihood of an individual having protective immunity against infection, the researchers state. AditxtScores model uses a novel flow-cytometry-based immune monitoring tool to determine levels of NAb following immunization.

The publication details a promising mathematical model that can serve as a foundation for predicting the decay rate of NAb over time. The model can assess variations in immune response against viral infection and vaccination to provide the opportunity for a more personalized approach to immunization protocols.

Knowing an individuals NAb level and how ones personal immune system responds to infection provides a valuable tool for health care providers and patients as they chart an individuals current and future health care needs.

Researchers concluded there are several potential applications for the AditxtScore model, including:

Story continues

Determining immune response on a case-by-case basis to identify vulnerable populations;

Aiding vaccine development by reducing clinical trial timelines and identifying vaccines that lead to a more robust immune response; and

More accurately assessing the timing of boosters on a personalized level.

To read the AditxtScore research paper published in the Journal of Theoretical Biology, visit: https://www.sciencedirect.com/science/article/pii/S0022519322002715

About Aditxt, Inc.

Aditxt is a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system. Aditxts immune monitoring technologies are designed to provide a personalized immune profile. Aditxts immune reprogramming technologies, currently preclinical, are being developed to retrain the immune system to induce tolerance to address rejection of transplanted organs, autoimmune diseases, and allergies.

For more information, please visit: http://www.Aditxt.com and http://www.AditxtScore.com

Forward-Looking Statements

Certain statements in this press release constitute "forward-looking statements" within the meaning of federal securities laws. Forward-looking statements include statements regarding the Company's intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things, the Company's ongoing and planned product and business development; the Company's intellectual property position; the Company's ability to develop commercial functions; expectations regarding product launch and revenue; the Company's results of operations, cash needs, spending, financial condition, liquidity, prospects, growth and strategies; the industry in which the Company operates; and the trends that may affect the industry or the Company. Forward-looking statements are not guarantees of future performance and actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, as well as market and other conditions and those risks more fully discussed in the section titled "Risk Factors" in the Company's most recent Annual Report on Form 10-K, as well as discussions of potential risks, uncertainties, and other important factors in the Company's other filings with the Securities and Exchange Commission. All such statements speak only as of the date made, and the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221012005475/en/

Contacts

ir@aditxt.com http://www.aditxt.com

See the original post:
Aditxt, Inc. (Nasdaq: ADTX) Announces Development and Publication of a Mathematical Model for Predicting Longevity and Variations of Immune Response...

MINNEAPOLIS, October 12, 2022--(BUSINESS WIRE)--FOXO Technologies Inc. (NYSEAM: FOXO), a technology platform company whose products and services seek to address long-standing, core problems within the life insurance industry through epigenetic longevity science, today announced that its insurance distribution subsidiary, FOXO LIFE, recruited its first distribution partner, California-based BGA Insurance, to begin rolling out Life Insurance Designed to Keep You Alive to agents across the state. FOXO also announced the appointment of James Grauel, Jr. as Chief Distribution Officer ("CDO") of FOXO LIFE to spearhead the launch of longevity-focused life insurance products with independent agents.

FOXO LIFE is partnering with leading independent insurance agencies across the United States who share its vision and goal of modernizing the industry. Grauel joins the team with decades of experience working in the life insurance industry from both the carrier and independent agent distribution viewpoints. As CDO, Grauel will manage the development of FOXO LIFEs network of independent agents selling longevity science-powered life insurance.

"I am thrilled to join a team that is building the most exciting thing Ive seen in this industry over the course of my career," said Jim Grauel, Jr., Chief Distribution Officer of FOXO LIFE. "Creating more value for life insurance consumers by aligning their healthy longevity with the natural financial interest of life insurance carriers is an incredible and obvious innovation the industry needs."

FOXO LIFE will be holding its first agent distribution rollout events in Southern California with BGA Insurance, its first broker-general agent, who represents over 4,000 independent agents who are now able to sell life insurance products with FOXO LIFEs Longevity Report.

Story continues

"We are excited to work with FOXO LIFE to bring our agent base the opportunity to reframe the life insurance conversation from death protection, to life, health, and longevity," said Barry Zimmerman, President. "The real game changer will be when FOXO LIFE introduces saliva-based underwriting protocols to mitigate the need for blood and urine specimen collection."

FOXO LIFEs first agent recruitment events will be held:

October 19th in Huntington Beach

November 1st in San Diego

November 2nd in Los Angeles, El Segundo

November 3rd in Sacramento, Roseville

For agents interested in attending an event contact Alicia at sales@foxolife.com or 888.405.8957.

"We like to say that FOXO LIFE was created by agents, for agents," said Jon Sabes, Founder and CEO of FOXO. "This means that the products and services we are bringing to market are designed to address major industry pain points that fall most directly on agents. Making it easier and more exciting for agents to sell life insurance is our first order of business."

Todays news comes four weeks after FOXO became a publicly traded company on the New York Stock Exchange American under the symbol "FOXO" via its merger with Delwinds Insurance Acquisition Corp ("Delwinds"), valuing the combined company at an estimated enterprise value of $369 million.

About FOXO Technologies Inc. ("FOXO")

FOXO is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. FOXO seeks to modernize the life insurance industry by simplifying the consumer underwriting journey with saliva-based biomarkers and enhancing life insurances consumer value proposition with the FOXO Longevity Report. For more information about FOXO, visit http://www.foxotechnologies.com. For more information about FOXO LIFE, visit http://www.foxolife.com. For investor information and updates, visit https://foxotechnologies.com/investors/.

No Offer or Solicitation

This press release shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the proposed transaction. This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended or an exemption therefrom.

Forward-Looking Statements

This press release contains certain forward-looking statements for purposes of the "safe harbor" provisions under the United States Private Securities Litigation Reform Act of 1995. Any statements other than statements of historical fact contained herein, including statements as to future results of operations and financial position, planned products and services, business strategy and plans, objectives of management for future operations of FOXO, market size and growth opportunities, competitive position and technological and market trends, are forward-looking statements. Such forward-looking statements include, but not limited to, expectations, hopes, beliefs, intentions, plans, prospects, financial results or strategies regarding FOXO and the future held by management teams of FOXO, the future financial condition and performance of FOXO and the products and markets and expected future performance and market opportunities of FOXO. These forward-looking statements generally are identified by the words "anticipate," "believe," "could," "expect," "estimate," "future," "intend," "strategy," "may," "might," "strategy," "opportunity," "plan," project," "possible," "potential," "project," "predict," "scales," "representative of," "valuation," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: (i) the risk that changes in the competitive and highly regulated industries in which FOXO operates, variations in operating performance across competitors, changes in laws and regulations affecting FOXOs business, and changes in the combined capital structure, (ii) the ability to implement FOXOs business plans, forecasts, and other expectations, (iii) potential inability of FOXO to establish or maintain relationships required to advance its goals or to achieve its commercialization and development plans, (iv) the enforceability of FOXOs intellectual property, including its patents and the potential infringement on the intellectual property rights of others, and (v) the risk of downturns and a changing regulatory landscape in the highly competitive biotechnology industry or in the markets or industries in which FOXOs prospective customers operate, including the highly regulated insurance industry. The foregoing list of factors is not exhaustive. Readers should carefully consider the foregoing factors and the other risks and uncertainties described in the "Risk Factors" filed with the SEC, and risks and uncertainties indicated in the Registration Statement, including those set forth under "Risk Factors" therein, and other documents filed or to be filed by FOXO from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and FOXO assumes no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221012005349/en/

Contacts

Contacts / Investor Relations Cody Slach, Matthew HauschGateway Investor Relations(949) 574-3860FOXO@gatewayir.com

The rest is here:
FOXO Technologies Announces First Distribution Partner and Begins Product Rollout in California; Expands Executive Team With Insurance Industry Talent...

Dr. Irving Berkowitz, the son of Holocaust survivors, is a renowned scholar and lecturer. He is passionately engaged in issues and causes related to the Holocaust, antisemitism, human rights and social justice. I have heard Dr. Irving lecture on several occasions, and recently had the opportunity to interview him. This is Part One of a two part series.

I started our conversation by asking Dr. Irving why raising awareness of social injustice is such a passion of his.

My passion for social justice, equal protection, non-discrimination and equality of opportunity is rooted in the very proud, deeply observant, socially aware and tragic history of my Jewish family. I am the son of immigrants, survivors of one of the worst atrocities in human history, the Holocaust. Having lost my entire extended family in the largest and most infamous of all Nazi death camps, Auschwitz/Birkenau, for no other reason than being Jewish. From an early age I had a mission that was spiritual and educational, to actively lead, serve and become educated, so I could educate others about antisemitism, racism, hatred, and violence. Both of my parents were not only Holocaust survivors but, like 75% of all survivors they were the sole survivors of their entire families in the former Czechoslovakia. This very personal family tragedy and the cataclysmic fate of my tribe, the Jewish people, loomed large in my life and briskly animated me to learn all that I possibly could about my people, including Jewish history, theology, and culture. I forged an inexorable and uncompromising commitment to becoming a Holocaust scholar with a deep well of knowledge about this longest hatred of Jews throughout history. It was upon this foundation that my interest and activism evolved to encompass the broader issues of the human condition, (e.g. human rights, human diversity, human dignity, and human development).

Dr. Irving explained why some people continue to deny that antisemitism exists.

Jew hatred has roots that run centuries deep in the soil of history. Its intensity, longevity and universality may only be exceeded by its irrationality. From its provenance in the early days of Christendom, throughout the Middle Ages when Jews were persecuted, isolated and expelled from virtually every European country they inhabited, during the pervasive pogroms of the 18th and 19th centuries, to the annihilation of European Jewry far and wide in the Nazi era, Jews have been scapegoated, blamed, brutalized and murdered en masse for others misfortune. There seems to be nothing evil for which Jews cannot be blamed. Indeed, everything evil is Jewish and everything Jewish is evil. This is most evident in countless daily Anti-Zionist/Antisemitic websites and posts across all major social media platforms despite supposed community standards designed to monitor and restrict content that is false, hateful, racist and violence inducing.

Dr. Irving continued, The denial of antisemitism is nearly as outrageous as the denial of the Holocaust. It flies in the face of irrefutable evidence amassed by the Anti-Defamation League that antisemitism in America, especially violent hate crimes, is not only on the rise but has reached record levels in the last three years, suggesting that deniers simply deny the undeniable. Perhaps more disconcerting than denial is the fact that so many dismiss antisemitism as a serious social issue, unworthy of the kind of attention garnered by other forms of bigotry such as racism, Islamophobia, homophobia, etc. Perhaps it has become so ingrained in the fabric of American society that seeing and or hearing of omnipresent antisemitic incidents has become normalized. Either way, antisemitism in America, Europe and elsewhere is not a thing of the past, vanquished with the fall of the Third Reich. It may have taken a brief sabbatical after the war but remains a pernicious and persistent virus coursing through the bloodstream of civilization, exacerbated by pervasive silence, denial and indifference.

I asked Dr. Irving, what can be done to curb or eliminate Holocaust denial on social media?

Few can argue about the enormous social, economic and cultural benefits of social media today. But just as obvious as its auspicious uses, is the weaponization of social media to deny, distort and revise history, to subvert the truth, to propagate and promote false narratives and stereotypes, and to advance an intolerant, dogmatic and fractious far left or far right agenda against Jewish people, communities, organizations and institutions. This, in my opinion, is how social media platforms are being used as flamethrowers of disinformation in the contemporaneous war against the Jews and the Nation/State of the Jewish people. The challenge of curbing the venomous role of social media in stoking Anti-Zionism, antisemitism and Holocaust denial may be formidable but not indomitable.

The most obvious, effective and strategic means of confronting this juggernaut is as follows:

1) Jews must rise above their own political and other differences, even forging coalitions with other targeted and affected ethnic or religious groups to create a sustained campaign of advocacy for more vigorous, consistent and equitable enforcement of community guidelines.

2) The captains of these social media giants must be confronted with their own organizational and employee biases and complicity in fomenting hate, violence, discrimination and denial through lax enforcement of their own published standards, particularly albeit not exclusively in relation to inauthentic, hate-filled, violence-inducing content they permit to be posted about Jews, Israel and the Holocaust. We must be uncompromising about the Holocaust, the most documented atrocity in human history, as a matter of historical fact, open neither to debate nor denial.

3) Finally, enforcement of community standards must be followed by swift and certain action holding those who abuse and/or flagrantly violate such policies accountable by expeditious removal of such harmful Antisemitic content. For those who regularly post Holocaust denying or endorsing material, social media companies must be willing to exercise the ultimate sanction, blocking or disabling accounts and account holders.

Daily

Start your day with the top stories in South Florida.

Dr. Irving expressed why Holocaust awareness is so important.

The value of Holocaust knowledge to Jews and non-Jews can best be appreciated when weighed against the cost of Holocaust ignorance. In less than 80 years since the worst genocide in history ended, surveys conducted in America and Europe have shockingly revealed a frightening low level of interest in and knowledge of the Holocaust. Even more concerning is the fact that among millennials and Generation Zrs, few have any knowledge of what concentration camps such as Auschwitz were or how they were used as factories of death.

Nearly half of this demographic havent a clue that 6 million Jews perished in the Holocaust. It is unconscionable to think so many know so little about an unparalleled atrocity such as the Holocaust. This prodigious lack of Holocaust knowledge resulting principally from the failure of most states to mandate Holocaust education lends an unpalatable measure of credence to the belief that this could happen again. In my opinion, the relevance of Holocaust knowledge is universal, not merely because it was the genocidal culmination of a racist ideology, in this case, antisemitism, but especially because the Holocaust is not exclusively a matter of Jewish history, but human history.

Dr. Irving continued, Learning about the Holocaust exposes and challenges us to understand the darker side of humanity, the motivation and capacity of people and societies to discriminate, dominate, segregate, subjugate and annihilate any racial, religious, ethnic or national group. Learning about the Holocaust raises our awareness of the ideological, political, economic, psycho-social and historical factors and forces that spawn conditions in which hatred, scapegoating, prejudice and persecution lead to state-sponsored violence and mass murder. It demonstrates how even the most enlightened, cultured and civilized society(ies) can turn to barbarism and genocide against a devalued and dehumanized segment of their population. This, in turn, allows us to highlight the perils of radical extremist ideologies and the central role of a propaganda apparatus in galvanizing hatred and rationalizing a campaign of genocide. On the level of human behavior, it enables us to grasp the many different choices people made and the roles they played in response to the unspeakable horrors committed by nefarious leaders and their obedient followers.

In conclusion of Part One of our conversation, Dr. Irving was asked what message he tries to pass on to young adults?

The core of my teaching and message to young people is the importance of doing good things. Be a lifelong learner, or as I say of myself, be a student of life and for life.

In Part Two of my conversation with Dr. Irving, he will share details of his career as an educator and lecturer.

Continued here:
A conversation with Holocaust scholar Dr. Irving Berkowitz - South Florida Sun Sentinel

NEW YORK, NY and SANTA BARBARA, CA The American Federation for Aging Research (AFAR) and the Glenn Foundation for Medical Research are pleased to announce the recipients of the2022 Glenn Foundation for Medical Research Postdoctoral FellowshipsinAgingResearch.Thisprogramsupportspostdoctoralfellowswhostudybasicresearchmechanisms of aging and/or translational findings that have potential to directly benefit human health.

Selected through a rigorous review process,nine,one-year,$60,000Postdoctoral Fellowshipshavebeenawarded this year to advance research on a range of topics in the biology of aging, geroscience, and potential therapeutics:

"The fellowships significant research and training support to permit postdoctoral fellows to develop skills and competencies needed to become established in the field of aging, " notes Stephanie Lederman, EdM, Executive Director of AFAR. "With this recognition, and the ability to develop an independent research project, they are more competitive when vying for coveted junior faculty positions and when applying for larger grant support."

Theseawardsprovidepostdoctoralfellowstheopportunitytodevelopindependentresearchprojects, notes Mark R. Collins, President of the Glenn Foundation for Medical Research. Their findings today will help deepen knowledge, foster collaborations, and further therapeutic interventions tomorrow.

Learn more about this grant programhereand the 2022 recipientshere.

###

About the Glenn Foundation for Medical Research- Founded by Paul F. Glenn in 1965, the mission of the Glenn Foundation for MedicalResearchistoextendthehealthyyearsoflifethroughresearchonmechanismsofbiologythatgovernnormalhumanaging and its related physiological decline, with the objective of translating research into interventions that will extend healthspan with lifespan. Learn more atglennfoundation.org.

AboutAFAR-The American Federation for Aging Research (AFAR) is a national non-profit organization that supports and advances pioneering biomedical research that is revolutionizing how we live healthier and longer. For more than four decades, AFAR has served as the fields talent incubator, providing more than $193 million to nearly 4350 investigators at premier research institutions to dateand growing. In 2022, AFAR is expected to award over $11,000,000 to more than 60 investigators. A trusted leader and strategist, AFAR also works with public and private funders to steer high quality grant programs and interdisciplinary research networks. AFAR-funded researchers are finding that modifying basic cellular processes can delayor even preventmany chronic diseases, often at the same time. They are discovering that it is never too lateor too earlyto improve health. This groundbreaking science is paving the way for innovative new therapies that promise to improve and extend our quality of lifeat any age. Learn more atwww.afar.orgor follow AFARorg on Twitter and Facebook and American Federation for Aging Research on LinkedIn.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Read this article:
Nine postdoctoral fellowships in aging research awarded by the Glenn Foundation for Medical Research and AFAR - EurekAlert

Staying on top of your overall health and wellness game as you grow older is not a question; it's a necessity. Self-care experiences, fitness routines that promote longevity, facials that put the glow back in aging skin, and anti-aging beauty products that promise to deliver results are all the rage, because people want to remain youthful for as long as possible. Living a long, healthy life may require more than a few tweaks to your regular routine, but don't stress. We've put together the wellness habits that slow down aging so you don't have to. Keep reading to learn more.

Getting your namaste on is not only relaxing; it can slow down the aging process. Many studies reveal that practicing yoga has a wealth of health benefits, including positively impacting cellular aging, balance, mobility, and mental health, along with warding off cognitive decline. These are all things that raise concerns among older individuals.

For example, a study published in the journal Oxidative Medicine and Cellular Longevity reveals that doing yoga for 12 weeks can slow down cellular aging among healthy individuals. Another study published in Frontiers in Human Neuroscience discovered that embarking on a yoga and meditation retreat for three months was linked to decreased stress and inflammation.6254a4d1642c605c54bf1cab17d50f1e

The next of the best wellness habits that slow down aging has to do with diet. According to Blue Zones, a Mediterranean diet can decrease your chance of developing heart disease and tack up to six years onto your life. It's what individuals in Ikaria, Greeceone of the Blue Zones, where many individuals live to 100 and beyondstick by. If you're unfamiliar with this diet, get familiar, because it's a golden key to longevity! The Mediterranean diet is all about olive oil, fresh veggies, whole grains, beans, some fish, and tinier portions of meat and dairy.

And research backs up just how great the Mediterranean diet is. According to Harvard T.H. Chan School of Public Health, research shows this particular diet can lengthen your lifespan and promote healthy aging.

Related: The Best Exercises To Live to 100 and Beyond, Trainer Reveals

You've likely heard this before, but preserving and building muscle mass as you get older is critical. According to Harvard Health Publishing, after you hit the age of 30, you start to lose anywhere from 3% to 5% of lean muscle mass every 10 years. This natural part of your body's aging process is called sarcopenia.

What can you do about it? Well, Landmark reports consuming protein, getting in strength training (specifically two to three half-hour workouts each week, after speaking with a medical professional), adding more omega-3s to your diet, keeping your vitamin D levels in check, and going on walks can all help preserve muscle mass.

Related: 5 Exercise Habits to Slow Muscle Aging, Trainer Reveals

Getting social is a major part of your health and wellness that shouldn't be overlooked. According to Mayo Clinic, socializing helps kick any feelings of loneliness to the curb, along with boosting your cognitive and memory skills, mood, and overall wellness. It can even help extend your life.

Mayo Clinic psychologist, Dr. Craig Sawchuk, explains, "We are social animals by nature, so we tend to function better when we're in a community and being around others." He says that people who spend much of their time by themselves have a greater chance of feeling depressed and leading an all-around lower quality of life.

Getting sufficient sleep is imperative to your overall wellness. According to News in Health, getting restful Z's can boost your mood and brain performance. Some say it's just as important to ensure you stay in good health as a solid workout routine and diet. Not getting enough solid sleep can put you at greater risk of developing disorders or diseases, such as obesity, heart disease, dementia, and stroke.

Sleep researcher at the University of Colorado, Dr. Kenneth Wright, Jr., explains, "There are certain repair processes that occur in the body mostly, or most effectively, during sleep. If you don't get enough sleep, those processes are going to be disturbed" (via NIH).

According to sleep expert at NIH, Dr. Marishka Brown, three key factors attribute to "healthy sleep." She says, "One is how much sleep you get. Another is sleep qualitythat you get uninterrupted and refreshing sleep. The last is a consistent sleep schedule."

Alexa Mellardo

Read this article:
The 5 Wellness Habits That Slow Down Aging, Science Reveals Eat This Not That - Eat This, Not That

[Bloomberg Government subscribers can stay up to date on important developments in new opportunities and existing contracts by setting an alert for our weekly Top 20 Opportunities update and by subscribing to our contracting newsletter. Not a subscriber? Request a demo.]

As we head into the new fiscal year, understanding annual federal spending data and recent trends can help you uncover actionable insights to build your pipeline with the right federal contracts. In the case of existing multi-year contract vehicles, track where the money is going and then start building relationships with primes on specific contracts to position yourself for partnering and teaming opportunities.

Start by researching the full spectrum of large contracting opportunities to home in on the most lucrative deals and understand where you have the highest PWIN, or probability to win. This includes agency-wide programs, large contracts, contract vehicles, and indefinite delivery indefinite quantity (IDIQ) contracts. Look for opportunities where you can differentiate yourself and add value either as a prime, partner, team member, or subcontractor determining the right contracts to pursue is imperative.

Scrolling through sam.gov searches can be tedious and doesnt guarantee youll catch every opportunity or update. Bloomberg Government expert analysts track the 20 largest upcoming opportunities and update the list on a weekly basis, so you can be sure to never miss a new development.

[Discover more relevant federal contracting opportunities. Bloomberg Governments Opportunity Search enables you to find and exclude keywords in documents attached to solicitation notices to surface relevant opportunities in no time at all. Request a demo.]

A lot of the most successful contractors are the ones who get as far left of the RFP as possiblemeaning building in as much lead time as they can before an RFP is due, sometimes even 1-4 years outso they can be strategic from the outset. Bloomberg Government provides estimated RFP and contract award dates for each of the top 20 opportunities in our Dashboard to support successful account planning for each fiscal year and quarter.

The advantage of using the top 20 opportunities to build your pipeline is that these programs have some longevity to them. Rather than chasing RFPs for single task orders or solicitations as they drop, building a long-term plan to compete for large opportunities with a multi-year lifespan means that your business development pipeline becomes more predictable.

Many contractors with current awards through these opportunities are looking for subcontractors or partners to deliver top-notch products and services to the federal government and help them stay ahead of the competition. By using this list of top 20 opportunities to track where the federal government is spending money and its potential value, you can target the primes on a specific contract to start building relationships now so you can take advantage of these opportunities in the future.

Link:
Winning Federal Contracts on the Top 20 Contract Vehicles - Bloomberg Government

Lt. Col. Lawrence B. Austin, Sr. was recently promoted and robed in ceremonies conducted in the Grenada County Circuit Court Room. Major General Janson D. Boyles conducted the pinning ceremony in which he promoted Lt. Col. Austin to the rank of Colonel. Following the pinning ceremony, Judge Virginia Carter Carlton, Presiding Judge of the Mississippi Court of Appeals, conducted an investiture ceremony in which she installed Col. Austin as The Military Judge, Mississippi Army National Guard.

Col. Austin entered military service in April 1994 as a First Lieutenant in the United States Army Reserve component of the Judge Advocate Generals Corps with the 213th Legal Support Organization (LSO). He served with Team 7, Fort Benning, as a Legal Assistance Attorney, and then Defense Counsel. In 1995, he moved to the Headquarters 23th LSO where he served as the Assistant Training Officer, and Administrative Law Counsel. In 1996, he moved to Jackson, Mississippi, where he served as the Administrative Law Counsel and then Contracts Law Counsel. He promoted to the rank of Captain in June of 1998, becoming Senior Legal Opinions Counsel in April 2002. Col. Austin received his promotion to the rank of Major in October of 2004.

Col. Austin was called to active service August of 2006 to Camp Shelby Joint Forces Training Center (CSJFTC) supporting mobilization operations. He initially served as Chief of Administrative Law, then Deputy Command Judge Advocate. COL Austin managed a staff of 7 attorneys, 2 paralegals, who successfully supported mobilization of over 26,000 service members, annually.

Col. Austins service with the Mississippi Army National Guard began in June of 2008, with an assignment as Command Judge Advocate for the 185th Theater Aviation Brigade. In August 2010, Col. Austin moved to the 184th Expeditionary Sustainment Command (ESC) as its Staff Judge Advocate, and mobilized with the unit to Kandahar Airfield, Afghanistan (Active Duty), where it operated as the Joint Sustainment Command Afghanistan. Col. Austin managed 5 law offices with numerous attorneys and paralegals, and received the Bronze Star Medal for his teams work resulting in millions of dollars in saving to the U.S. Government.

In 2012, Col. Austin again entered active service with the 177th Armored Brigade as its Command Judge Advocate and Special Subjects Trainer, and Judge Advocate for the 151 Infantry Brigade supporting training, mobilization and demobilization operations. Following his active-duty tour, Col. Austin returned to the MSARNG in 2014, and served as Deputy Staff Judge Advocate, 66th Troop Command; Staff Judge Advocate, Special Operations Command Detachment South; Assistant Staff Judge Advocate, Joint Forces Headquarters; Chief of Trial Defense Service; and Command Judge Advocate, Camp McCain Training Center. He was promoted to Lieutenant Colonel in August of 2009.

Col. Austin has represented the

MSARNG before the Mississippi Public Service Commission, and was instrumental in the creation of Mississippi legislation related to Commercial Licensing for Military Service Members.

His awards include: Bronze Star Medal; Meritorious Service Medal; Army Commendation Medal (2nd Award); Army Reserve Component Achievement Medal; Afghanistan Campaign Medal (2 Campaign Stars); NATO Medal; Afghanistan Service Medal; National Defense Service Medal (with Bronze Service Star); Global War on Terrorism Service Medal; Army Service Ribbon; Overseas Service Ribbon (2nd award); Army Reserve Component Overseas Training Ribbon (2nd Award); Armed Forces Reserve Medal (with M Device); Mississippi War Medal; Mississippi National Guard Emergency Service Medal Ribbon; Mississippi Longevity Medal (10th award); and the Joint Meritorious Unit Award.

COL Austin civilian education includes a Bachelors of Business Administration from Delta State University, a Juris Doctor from Mississippi College School of Law, and a Masters of Law in Taxation from University of Denver Graduate Tax Program. His military education includes the Command and General Staff College Advanced Operations Course, and Intermediate Level Education Course (Top 10% of Class); The Judge Advocate Officer Basic and Advanced Courses; The Adjutant General School Human Resource Management Course; U.S. Air Force Joint Special Operations Course; U.S. Naval Justice School Law of Naval Warfare Course; Range Safety Level II Course and Range Operations Course.

COL Austin (son of the former Mr. Cecil and Mrs. Bobbie Austin and grandson of Mr. and Mrs. John L. Baskin) is married to Josephine Thompson Saunders Ashcraft Austin (daughter of the former Mr. and Mrs. John D. Ashcraft, Jr.), and they have two children, Amanda Josephine Ashcraft Austin Goodwin and Specialist Lawrence Bryant Austin, Jr., and son-in-law Danner Stribling Goodwin. He is the son of the former. COL Austin a member of the Winona Rotary Club serving as Vice-president, and Moore Memorial United Methodist Church.

Link:
Lawrence Austin promoted to rank of colonel - Winona Times